Intravenous Immunoglobulin (IVIG) for Treatment of Unexplained Secondary Recurrent Miscarriage

This study is ongoing, but not recruiting participants.

Study NCT00606905 Information provided by University of Chicago

First Received: January 23, 2008 Last Updated: July 25, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	January 2010
Estimated Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)